Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald G Foellmer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Vaccine|May 27, 2005
A recombinant envelope protein vaccine against West Nile virusMichel Ledizet, Kalipada Kar, Harald G Foellmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2012
Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-β1/Smad6 signalingHameeda Sultana, Girish Neelakanta, Harald G Foellmer, et al.
The Journal of Infectious Diseases|January 15, 2008
Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virusMichel Ledizet, Kalipada Kar, Harald G Foellmer, et al.
The Journal of Clinical Investigation|October 3, 2007
Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasionAlvaro Arjona, Harald G Foellmer, Terrence Town, et al.
Vaccine|May 12, 2009
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacyStacey L Demento, Stephanie C Eisenbarth, Harald G Foellmer, et al.
Vaccine|November 11, 2008
A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cellsNathalie Bonafé, Joseph A Rininger, Richard G Chubet, et al.
The Journal of Infectious Diseases|May 2, 2007
A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunityWilliam F McDonald, James W Huleatt, Harald G Foellmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2009
Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibodyHameeda Sultana, Harald G Foellmer, Girish Neelakanta, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Vaccine|May 27, 2005
A recombinant envelope protein vaccine against West Nile virusMichel Ledizet, Kalipada Kar, Harald G Foellmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2012
Semaphorin 7A contributes to West Nile virus pathogenesis through TGF-β1/Smad6 signalingHameeda Sultana, Girish Neelakanta, Harald G Foellmer, et al.
The Journal of Infectious Diseases|January 15, 2008
Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virusMichel Ledizet, Kalipada Kar, Harald G Foellmer, et al.
The Journal of Clinical Investigation|October 3, 2007
Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasionAlvaro Arjona, Harald G Foellmer, Terrence Town, et al.
Vaccine|May 12, 2009
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacyStacey L Demento, Stephanie C Eisenbarth, Harald G Foellmer, et al.
Vaccine|November 11, 2008
A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cellsNathalie Bonafé, Joseph A Rininger, Richard G Chubet, et al.
The Journal of Infectious Diseases|May 2, 2007
A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunityWilliam F McDonald, James W Huleatt, Harald G Foellmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2009
Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibodyHameeda Sultana, Harald G Foellmer, Girish Neelakanta, et al.
Pageof 1